✦ LIBER ✦

Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine

✍ Scribed by Haruhiko Kobashi; Yasuhiro Miyake; Fusao Ikeda; Tetsuya Yasunaka; Ken Nishino; Akio Moriya; Jyunichi Kubota; Shinichiro Nakamura; Akinobu Takaki; Kazuhiro Nouso; Gotaro Yamada; Kazuhide Yamamoto

Book ID: 118088392
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 681 KB
Volume: 41
Category: Article
ISSN: 1386-6346
DOI: 10.1111/j.1872-034x.2011.00785.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

727 LONG-TERM EFFICACY AND IMPACT ON HEP

727 LONG-TERM EFFICACY AND IMPACT ON HEPATOCELLULAR CARCINOMA DEVELOPMENT OF NUCLEOSIDE ANALOGUE TREATMENT WITH LAMIVUDINE AND ENTECAVIR FOR CHRONIC HEPATITIS B AND CIRRHOSIS

✍ H. Kobashi; Y. Miyake; F. Ikeda; T. Yasunaka; K. Nishino; A. Moriya; J.-I. Kubot 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Loss of HBsAg antigen during treatment w

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

✍ R. G. Gish; T.-T. Chang; C.-L. Lai; R. De Man; A. Gadano; F. Poordad; J. Yang; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB